Patents by Inventor David A. Hickman
David A. Hickman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11958889Abstract: Liposomes containing tau peptides, preferably phosphorylated tau peptides, and conjugates containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier are described. Pharmaceutical compositions and uses of the liposomes and/or conjugates for treating or preventing a neurodegenerative disease or disorder, such as Alzheimer's Disease, are also described.Type: GrantFiled: October 24, 2018Date of Patent: April 16, 2024Assignees: Janssen Pharmaceuticals, Inc., AC Immune SAInventors: Elizabeth Anne Ramsburg, Donata de Marco, Charlotte Sadaka, Jaap Goudsmit, Andreas Muhs, Maria Pihlgren Bosch, Marija Vukicevic Verhille, David Hickman, Nicolas Piot, Saroj Raj Ghimire
-
Publication number: 20230392477Abstract: The invention relates to an umbilical for use between an offshore construction (10) and a seabed installation (20), comprising one or more of longitudinal umbilical elements, such as one or more filler element, one or more signal cable, one or more fiber optic, one or more electrical power cable, and/or one or more load carrying element like carbon fiber rod, the umbilical further comprises at least one fluid pipe (1a, 1b) arranged within the umbilical (1), the longitudinal umbilical elements (1a, 1b) and the at least one fluid pipe (1a, 1b) are either laid in a continuous helix, or alternatingly/oscillatory laid within the umbilical. The at least one fluid pipe (1a, 1b) is a mix of at least one seamless pipe (1a) and at least one seam-welded pipe (1b), the at least one seamless pipe (1a) and the at least one seam-welded pipe (1b) are spliced together at one or more predetermined locations in the longitudinal direction of the umbilical (1).Type: ApplicationFiled: November 4, 2021Publication date: December 7, 2023Applicant: AKER SOLUTIONS ASInventor: David HICKMAN
-
Publication number: 20230257433Abstract: Methods for inducing an immune response against tau protein in a subject suffering from a neurodegenerative disease, disorder or condition, such as Alzheimer's Disease, are described. The methods include administering a liposomal priming composition containing tau peptides, preferably phosphorylated tau peptides, and a conjugate boosting composition containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier.Type: ApplicationFiled: February 20, 2023Publication date: August 17, 2023Inventors: Elizabeth Anne Ramsburg, Donata De Marco, Chakkumkal Anish, Charlotte Sadaka, Jaap Goudsmit, Andreas Muhs, Maria Pihlgren Bosch, Marija Vukicevic Verhille, David Hickman, Nicolas Piot, Saroj Raj Ghimire
-
Patent number: 11591377Abstract: Methods for inducing an immune response against tau protein in a subject suffering from a neurodegenerative disease, disorder or condition, such as Alzheimer's Disease, are described. The methods include administering a liposomal priming composition containing tau peptides, preferably phosphorylated tau peptides, and a conjugate boosting composition containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier.Type: GrantFiled: April 23, 2020Date of Patent: February 28, 2023Assignees: Janssen Pharmaceuticals, Inc., AC Immune SAInventors: Elizabeth Anne Ramsburg, Donata De Marco, Chakkumkal Anish, Charlotte Sadaka, Jaap Goudsmit, Andreas Muhs, Maria Pihlgren Bosch, Marija Vukicevic Verhille, David Hickman, Nicolas Piot, Saroj Raj Ghimire
-
Publication number: 20220375650Abstract: Power umbilical (1) comprising a plurality of power cables (7) for electric power transmission, elongated filler elements (5), and an outer sheath (3). The elongated filler elements (5) abut against each other at abutment faces (5a), thereby forming a complete ring enclosing the power cables (7). The elongated filler elements (5) comprise cable recesses (5b) within which the power cables (7) are embedded. The power umbilical (1) further comprises one or more friction control profiles (13, 15, 116), wherein the material of the friction control profile (13, 15, 116) is softer than the material of the elongated filler elements (5). The one or more friction control profiles (13, 15) are arranged in a deformed state.Type: ApplicationFiled: May 10, 2022Publication date: November 24, 2022Applicant: Aker Solutions ASInventors: Arild Figenschou, Mehrdad KARIMPOUR, David HICKMAN, Kevin LERCH
-
Patent number: 11458111Abstract: A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient. Also provided are compositions and kits finding use in practicing embodiments of the methods.Type: GrantFiled: May 4, 2020Date of Patent: October 4, 2022Assignee: ZOGENIX INTERNATIONAL LIMITEDInventors: Khawla Abu-Izza, David Hickman, Glenn Morrison, Brooks M. Boyd
-
Publication number: 20220174940Abstract: An article of manufacture for providing a quick and dry decoy retrieval device includes a decoy body shaped as a waterfowl, an anchor line having an upper end and a lower end, an anchor weight coupled to the lower end of the anchor line, the anchor weight and the lower end are below the underside surface, and a finger retrieval loop coupled to the upper end. The decoy body having an upper surface, a head, an underside surface, and a waterfowl decoy keel, and a concealment cavity located in the top surface behind the head, an anchor line channel running from an entry point within the concealment cavity to an exit point on the underside surface about the waterfowl decoy keel. The anchor line being routed through the anchor line channel. The finger retrieval loop being concealed within the concealment cavity when the upper end e is about the entry.Type: ApplicationFiled: December 3, 2020Publication date: June 9, 2022Inventors: David Hickman, III, Stephen Hickman
-
Publication number: 20210388044Abstract: Liposomes containing tau peptides, preferably phosphorylated tau peptides, and conjugates containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier are described. Pharmaceutical compositions and uses of the liposomes and/or conjugates for treating or preventing a neurodegenerative disease or disorder, such as Alzheimer's Disease, are also described.Type: ApplicationFiled: August 19, 2021Publication date: December 16, 2021Inventors: Elizabeth Anne Ramsburg, Anish Chakkumkal, David Hickman
-
Publication number: 20200376078Abstract: Liposomes containing tau peptides, preferably phosphorylated tau peptides, and conjugates containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier are described. Pharmaceutical compositions and uses of the liposomes and/or conjugates for treating or preventing a neurodegenerative disease or disorder, such as Alzheimer's Disease, are also described.Type: ApplicationFiled: October 24, 2018Publication date: December 3, 2020Inventors: Elizabeth Anne RAMSBURG, Donata DE MARCO, Anish CHAKKUMKAL, Charlotte SADAKA, Jaap GOUDSMIT, Andreas MUHS, Maria PIHLGREN BOSCH, Marija VUKICEVIC VERHILLE, David HICKMAN, Nicolas PIOT, Saroj Raj GHIMIRE
-
Publication number: 20200339643Abstract: Methods for inducing an immune response against tau protein in a subject suffering from a neurodegenerative disease, disorder or condition, such as Alzheimer's Disease, are described. The methods include administering a liposomal priming composition containing tau peptides, preferably phosphorylated tau peptides, and a conjugate boosting composition containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier.Type: ApplicationFiled: April 23, 2020Publication date: October 29, 2020Inventors: Elizabeth Anne RAMSBURG, Donata DE MARCO, Anish CHAKKUMKAL, Charlotte SADAKA, Jaap GOUDSMIT, Andreas MUHS, Maria PIHLGREN BOSCH, Marija VUKICEVIC VERHILLE, David HICKMAN, Nicolas PIOT, Saroj Raj GHIMIRE
-
Publication number: 20200261380Abstract: A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient. Also provided are compositions and kits finding use in practicing embodiments of the methods.Type: ApplicationFiled: May 4, 2020Publication date: August 20, 2020Inventors: Khawla ABU-IZZA, David HICKMAN, Glenn MORRISON, Brooks M. BOYD
-
Patent number: 10682317Abstract: A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient. Also provided are compositions and kits finding use in practicing embodiments of the methods.Type: GrantFiled: September 24, 2018Date of Patent: June 16, 2020Assignee: ZOGENIX INTERNATIONAL LIMITEDInventors: Khawla Abu-Izza, David Hickman, Glenn Morrison, Brooks M. Boyd
-
Publication number: 20190119341Abstract: Liposomes containing tau peptides, preferably phosphorylated tau peptides, and conjugates containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier are described. Pharmaceutical compositions and uses of the liposomes and/or conjugates for treating or preventing a neurodegenerative disease or disorder, such as Alzheimer's Disease, are also described.Type: ApplicationFiled: October 24, 2018Publication date: April 25, 2019Inventors: Elizabeth Anne Ramsburg, Donata De Marco, Anish Chakkumkal, Charlotte Sadaka, Jaap Goudsmit, Andreas Muhs, Maria Pihlgren Bosch, Marija Vukicevic Verhille, David Hickman, Nicolas Piot, Saroj Raj Ghimire
-
Publication number: 20190091178Abstract: A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient. Also provided are compositions and kits finding use in practicing embodiments of the methods.Type: ApplicationFiled: September 24, 2018Publication date: March 28, 2019Applicant: ZOGENIX INTERNATIONAL LIMITEDInventors: Khawla ABU-IZZA, David HICKMAN, Glenn MORRISON, Brooks M. BOYD
-
Patent number: 10053125Abstract: A cart transportation assembly includes a frame including at least one upright and a top rail supported by the upright(s). The top rail includes a main body portion, an actuation rod, and at least one cart latch coupled to the actuation rod. The actuation rod is movable relative to the main body portion to transition the cart latch(es) between release and restrain positions. A platform provides structural support for the frame and includes a deck for supporting at least one cart. The cart latch(es), when in the release position, is/are adapted to allow movement of the at least one cart on the deck of the platform. The cart latch(es), when in the restrain position, is/are adapted to restrain movement of the at least one cart on the deck of the platform by pulling the at least one cart towards and against or in close proximity to the frame.Type: GrantFiled: April 26, 2017Date of Patent: August 21, 2018Assignee: Crown Equipment CorporationInventors: Clinton Reges, David Hickman, Daniel Magoto
-
Patent number: 9975946Abstract: The present invention comprises novel compositions and methods for eliciting high immune responses, of great specificity yielding conformationally sensitive antibodies. These antibodies recognize specific epitopes on a wide variety of antigens including but not limited to, amyloid protein, prion protein, P170 glycoprotein. The novel compositions of the invention comprise supramolecular antigenic constructs generally comprising a peptide sequence, covalently attached to pegylated lysine resulting in modified and enhanced peptide presentation. The unique modification methodology of the present invention is applicable to a variety of peptides and can ultimately be employed in therapeutic formulations and vaccines for diseases and disorders such as Alzheimer's disease.Type: GrantFiled: November 26, 2014Date of Patent: May 22, 2018Assignee: AC Immune SAInventors: Yves Claude Nicolau, Ruth Greferath, David Hickman
-
Patent number: 9840350Abstract: The present application discloses a pallet truck backrest assembly for handling half-size pallets. A first half-size pallet support is pivotally coupled to a backrest of the backrest assembly at a first height and a second half-size pallet support is pivotally coupled to the backrest at a second height with the second height being less than the first height. The half-size pallet supports pivot between first positions against the backrest and second positions extending over the forks of the pallet truck to accommodate half-size pallets.Type: GrantFiled: November 3, 2015Date of Patent: December 12, 2017Assignee: Crown Equipment CorporationInventors: Michael J. Moran, Brad A. Halbert, David A. Hickman
-
Publication number: 20170313335Abstract: A cart transportation assembly includes a frame including at least one upright and a top rail supported by the upright(s). The top rail includes a main body portion, an actuation rod, and at least one cart latch coupled to the actuation rod. The actuation rod is movable relative to the main body portion to transition the cart latch(es) between release and restrain positions. A platform provides structural support for the frame and includes a deck for supporting at least one cart. The cart latch(es), when in the release position, is/are adapted to allow movement of the at least one cart on the deck of the platform. The cart latch(es), when in the restrain position, is/are adapted to restrain movement of the at least one cart on the deck of the platform by pulling the at least one cart towards and against or in close proximity to the frame.Type: ApplicationFiled: April 26, 2017Publication date: November 2, 2017Inventors: Clinton Reges, David Hickman, Daniel Magoto
-
Patent number: 9687447Abstract: The present invention relates to method for preparing liposome-based constructs comprising a peptide, particularly an antigenic peptide, of interest modified through hydrophobic moieties reconstituted in liposomes and to the antigenic constructs obtained with said method. The invention further relates to the use of said constructs for the therapeutic and diagnostic use in the treatment of diseases and disorders, which are caused by or associated with proteopathy such as Alzheimer's Disease.Type: GrantFiled: October 26, 2011Date of Patent: June 27, 2017Assignee: AC Immune S.A.Inventors: Pedro Reis, David Hickman, Maria Pihlgren Bosch, Andreas Muhs, Andrea Pfeifer
-
Publication number: 20160122077Abstract: The present application discloses a pallet truck backrest assembly for handling half-size pallets. A first half-size pallet support is pivotally coupled to a backrest of the backrest assembly at a first height and a second half-size pallet support is pivotally coupled to the backrest at a second height with the second height being less than the first height. The half-size pallet supports pivot between first positions against the backrest and second positions extending over the forks of the pallet truck to accommodate half-size pallets.Type: ApplicationFiled: November 3, 2015Publication date: May 5, 2016Inventors: Michael J. Moran, Brad A. Halbert, David A. Hickman